Get started
Author

Amit Kalra

Observed names: A. Kalra, AMIT KALRA, Kalra, Amit
ORCID: 0000-0001-6879-268X
Observed ORCID: 0000-0001-6879-268X
OpenAlex ID: A5115599350
Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19
2020 · Mohammed Osman, Rehan M. Faridi, et al. · Blood Advances · 130
PDF
Impact of Donor and Recipient Cytomegalovirus Serostatus on Outcomes of Antithymocyte Globulin–Conditioned Hematopoietic Cell Transplantation
2016 · Amit Kalra, Tyler Williamson, et al. · Transplantation and Cellular Therapy · 50
High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era
2019 · Christopher Evernden, Michelle Dowhan, et al. · Cytotherapy · 30
Epstein-barr virus DNAemia monitoring for the management of post-transplant lymphoproliferative disorder
2018 · Amit Kalra, Cameron Roessner, et al. · Cytotherapy · 29
Risk factors for post‐transplant lymphoproliferative disorder after Thymoglobulin‐conditioned hematopoietic cell transplantation
2017 · Amit Kalra, Cameron Roessner, et al. · Clinical Transplantation · 27
Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation
2021 · Megan Kinzel, Michelle Dowhan, et al. · Transplantation and Cellular Therapy · 24
PDF
Rituximab Toxicity after Preemptive or Therapeutic Administration for Post-Transplant Lymphoproliferative Disorder
2022 · Megan Kinzel, Amit Kalra, et al. · Transplantation and Cellular Therapy · 17
Hematopoietic cell transplant outcomes after myeloablative conditioning with fludarabine, busulfan, low‐dose total body irradiation, and rabbit antithymocyte globulin
2020 · Samar Ousia, Amit Kalra, et al. · Clinical Transplantation · 16
A biomarker-guided, prospective, phase 2 trial of pre-emptive graft-versus-host disease therapy using anti-thymocyte globulin
2021 · Rutvij A. Khanolkar, Amit Kalra, et al. · Cytotherapy · 10
Lack of both donor and recipient anti-EBV T cells in EBV seronegative recipients of grafts from seropositive donors
2022 · Megan Kinzel, Amit Kalra, et al. · Bone Marrow Transplantation · 9
Donor Genetic Predisposition to High Interleukin-10 Production Appears Protective against Acute Graft-Versus-Host Disease
2022 · Gaurav Tripathi, Rutvij A. Khanolkar, et al. · International Journal of Molecular Sciences · 5
PDF
Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease
2022 · Rutvij A. Khanolkar, Gaurav Tripathi, et al. · Cytotherapy · 3
Curability and transferability of atopy with allogeneic hematopoietic cell transplantation
2020 · Sarah Whiteside, Alex Chin, et al. · Bone Marrow Transplantation · 3
High incidence of hematologic malignancy relapse after allogeneic transplantation in patients with low Epstein-Barr virus–specific T-cell counts
2019 · MEHUL GUPTA, SUNAND KANNAPPAN, et al. · Cytotherapy · 2
DNA Methylation Changes in Nucleated Red Blood Cells from Patients with Sickle Cell Disease: A Potential Marker of Engraftment after Stem Cell Transplantation
2023 · Jasmine Lewis, Nicolas Prud'homme, et al. · Blood · 1
Differential Expression of Immunity Related Genes Can Predict Moderate-Severe Chronic GvHD Early after Myeloablative Hematopoietic Stem Cell Transplantation.
2019 · Amit Kalra, Poonam Dharmani-Khan, et al. · Transplantation and Cellular Therapy · 1
Cytomegalovirus (CMV) Serostatus: High Importance of Choosing Seropositive Donors for Seropositive Patients When Using Rabbit Antithymocyte Globulin (ATG)
2015 · Amit Kalra, Andrew Daly, et al. · Blood · 1
Protective Role of Donor KIR B Haplotype in Cytomegalovirus Reactivation Following T-Cell-Depleted Hematopoietic Stem Cell Transplantation
2026 · Rehan M. Faridi, Nazanin Vaziri, et al. · Cells
PDF
Reconstitution of T cells at three months after stem cell transplant influences the discovery of predictive markers of relapse
2024 · A. Kalra, R. Faridi, et al. · Human Immunology
Mild clinical course of SARS-coronavirus-2 infection early posttransplant in patients with adoptively transferred antibody response
2021 · Jan Storek, Jamil N. Kanji, et al. · Bone Marrow Transplantation
PDF
Early Prediction of Moderate-Severe Chronic GvHD By Immunity Related Transcriptome
2018 · Amit Kalra, Poonam Dharmani-Khan, et al. · Blood
Differential Expression of Immunity Related Genes and Early Prediction of Severe Graft Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation
2016 · Poonam Dharmani-Khan, Rehan Mujeeb Faridi, et al. · Blood
Limited Efficacy of Prompt Therapy of Posttransplant Lymphoproliferative Disorder (PTLD) with Rituximab
2015 · Amit Kalra, Cameron Roessner, et al. · Blood
Works count: 24
Citation count: 358
H-index: 9
I10-index: 9
Year
Topic
Type